glp-1 egfr cut off Updated algorithm to choose the optimum antidiabetic therapy between Chronic Kidney Disease | Ozempic®

Highlights of Prescribing Information: BYETTA (exenatide) injection, for subcutaneous use

Is it an FDA-approved brand or compounded

Its unsuitable for those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2

They concluded that incretin-based medications did not correlate with an increased risk of acute pancreatitis or pancreatic cancer compared to other oral anti-diabetic agents, which remained consistent across drug classification and duration of use [29,55]

Here's What Dietitians Say Potential Risks of GLP-1 Agonists Although GLP-1 medications can be highly effective, they are not without some risks